Kamada (KMDA) Accumulated Expenses (2012 - 2026)

Kamada (KMDA) posted quarterly Accumulated Expenses of $24.9 million for Q1 2026, up 29.04% year-on-year from $19.3 million in Q1 2025, and up 105.9% on a QoQ basis from $12.1 million in Q4 2025.

Kamada (KMDA) Accumulated Expenses (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Accumulated Expenses for 15 consecutive years, with $24.9 million the latest figure, recorded in Q1 2026.

  • Quarterly Accumulated Expenses rose 29.04% year-over-year to $24.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.9 million (up 29.04% YoY) and the FY2025 annual result came in at $12.1 million, up 25.2% from the prior year.
  • Accumulated Expenses advanced to $24.9 million in Q1 2026 per KMDA's latest filing, from $12.1 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for KMDA reached as high as $24.9 million in Q1 2026 and fell as low as $7350.0 in Q1 2023.
  • A 5-year average of $8.8 million and a median of $7.6 million in 2022 frame the typical range for Accumulated Expenses.
  • The largest YoY upside for Accumulated Expenses was 91973.48% in 2023 against a maximum downside of 99.89% in 2023.
  • Year by year, Accumulated Expenses stood at $7.6 million in 2022, then climbed by 8.91% to $8.3 million in 2023, then increased by 17.07% to $9.7 million in 2024, then increased by 25.2% to $12.1 million in 2025, then soared by 105.9% to $24.9 million in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $24.9 million, $12.1 million, and $9.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 24.93 Mn
Dec 31, 2025 12.11 Mn
Sep 30, 2025 9.44 Mn
Jun 30, 2025 8.80 Mn
Mar 31, 2025 19.32 Mn
Dec 31, 2024 9.67 Mn
Sep 30, 2024 8.10 Mn
Jun 30, 2024 7.23 Mn
Mar 31, 2024 6.21 Mn
Dec 31, 2023 8.26 Mn
Sep 30, 2023 7.32 Mn
Jun 30, 2023 7.24 Mn
Mar 31, 2023 7,350.00
Dec 31, 2022 7.59 Mn
Sep 30, 2022 7,948.00
Jun 30, 2022 6.11 Mn
Mar 31, 2022 6.67 Mn
Dec 31, 2021 7.14 Mn
Sep 30, 2021 6.35 Mn
Jun 30, 2021 6.99 Mn